Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael L Friedlander

Showing results (61-70 of 76) with videos related to

Pageof 8
Sort By:
Breast Cancer Research : BCR|November 30, 2019
Alcohol consumption, cigarette smoking, and familial breast cancer risk: findings from the Prospective Family Study Cohort (ProF-SC)Nur Zeinomar, Julia A Knight, Jeanine M Genkinger, et al.
Breast Cancer Research : BCR|November 5, 2018
Age-specific breast cancer risk by body mass index and familial risk: prospective family study cohort (ProF-SC)John L Hopper, Gillian S Dite, Robert J MacInnis, et al.
Breast Cancer Research : BCR|April 20, 2019
Regular use of aspirin and other non-steroidal anti-inflammatory drugs and breast cancer risk for women at familial or genetic risk: a cohort studyRebecca D Kehm, John L Hopper, Esther M John, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 8, 2013
Efficacy of chemotherapy in BRCA1/2 mutation carrier ovarian cancer in the setting of PARP inhibitor resistance: a multi-institutional studyJoo Ern Ang, Charlie Gourley, C Bethan Powell, et al.
The Lancet. Oncology|February 26, 2019
10-year performance of four models of breast cancer risk: a validation studyMary Beth Terry, Yuyan Liao, Alice S Whittemore, et al.
Journal of the National Cancer Institute|October 5, 2019
Considerations When Using Breast Cancer Risk Models for Women with Negative BRCA1/BRCA2 Mutation ResultsRobert J MacInnis, Yuyan Liao, Julia A Knight, et al.
JNCI Cancer Spectrum|December 24, 2021
Recreational Physical Activity and Outcomes After Breast Cancer in Women at High Familial RiskRebecca D Kehm, Robert J MacInnis, Esther M John, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 2, 2024
Hormonal Contraception and Breast Cancer Risk for Carriers of Germline Mutations in <i>BRCA1</i> and <i>BRCA2</i>Kelly-Anne Phillips, Joanne Kotsopoulos, Susan M Domchek, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 7, 2013
Tamoxifen and risk of contralateral breast cancer for BRCA1 and BRCA2 mutation carriersKelly-Anne Phillips, Roger L Milne, Matti A Rookus, et al.
Gynecologic Oncology|November 11, 2022
Profiling the immune landscape in mucinous ovarian carcinomaNicola S Meagher, Phineas Hamilton, Katy Milne, et al.
Pageof 8

Showing results (61-70 of 76) with videos related to

Sort By:
Pageof 8
Breast Cancer Research : BCR|November 30, 2019
Alcohol consumption, cigarette smoking, and familial breast cancer risk: findings from the Prospective Family Study Cohort (ProF-SC)Nur Zeinomar, Julia A Knight, Jeanine M Genkinger, et al.
Breast Cancer Research : BCR|November 5, 2018
Age-specific breast cancer risk by body mass index and familial risk: prospective family study cohort (ProF-SC)John L Hopper, Gillian S Dite, Robert J MacInnis, et al.
Breast Cancer Research : BCR|April 20, 2019
Regular use of aspirin and other non-steroidal anti-inflammatory drugs and breast cancer risk for women at familial or genetic risk: a cohort studyRebecca D Kehm, John L Hopper, Esther M John, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 8, 2013
Efficacy of chemotherapy in BRCA1/2 mutation carrier ovarian cancer in the setting of PARP inhibitor resistance: a multi-institutional studyJoo Ern Ang, Charlie Gourley, C Bethan Powell, et al.
The Lancet. Oncology|February 26, 2019
10-year performance of four models of breast cancer risk: a validation studyMary Beth Terry, Yuyan Liao, Alice S Whittemore, et al.
Journal of the National Cancer Institute|October 5, 2019
Considerations When Using Breast Cancer Risk Models for Women with Negative BRCA1/BRCA2 Mutation ResultsRobert J MacInnis, Yuyan Liao, Julia A Knight, et al.
JNCI Cancer Spectrum|December 24, 2021
Recreational Physical Activity and Outcomes After Breast Cancer in Women at High Familial RiskRebecca D Kehm, Robert J MacInnis, Esther M John, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 2, 2024
Hormonal Contraception and Breast Cancer Risk for Carriers of Germline Mutations in <i>BRCA1</i> and <i>BRCA2</i>Kelly-Anne Phillips, Joanne Kotsopoulos, Susan M Domchek, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 7, 2013
Tamoxifen and risk of contralateral breast cancer for BRCA1 and BRCA2 mutation carriersKelly-Anne Phillips, Roger L Milne, Matti A Rookus, et al.
Gynecologic Oncology|November 11, 2022
Profiling the immune landscape in mucinous ovarian carcinomaNicola S Meagher, Phineas Hamilton, Katy Milne, et al.
Pageof 8